These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
166 related items for PubMed ID: 10687263
1. [The clinical usefulness of cyclosporine therapeutic monitoring]. Di Fede G, Iacò V, Pepe S, Salerno L. Clin Ter; 1999; 150(5):339-42. PubMed ID: 10687263 [Abstract] [Full Text] [Related]
2. Evaluation of the therapeutic range of whole blood cyclosporin concentration in the treatment of psoriasis. Ieiri I, Nakayama J, Murakami H, Hori Y, Higuchi S. Int J Clin Pharmacol Ther; 1996 Mar; 34(3):106-11. PubMed ID: 8705088 [Abstract] [Full Text] [Related]
3. Optimal time for therapeutic drug monitoring of cyclosporine microemulsion in patients with psoriasis. Umezawa Y, Ozawa A. Int J Dermatol; 2007 Jul; 46(7):763-6. PubMed ID: 17614813 [Abstract] [Full Text] [Related]
4. Comparison of cyclosporine concentrations 2 hours post-dose determined using 3 different methods and trough level in pediatric renal transplantation. Rodríguez E, Delucchi MA, Cano F, Valdebenito S, Castillo MC, Villegas R. Transplant Proc; 2005 Oct; 37(8):3354-7. PubMed ID: 16298594 [Abstract] [Full Text] [Related]
5. Therapeutic drug monitoring of cyclosporine. Midtvedt K. Transplant Proc; 2004 Mar; 36(2 Suppl):430S-433S. PubMed ID: 15041380 [Abstract] [Full Text] [Related]
6. Cyclosporine monitoring in renal transplant recipients with induction therapy: C2 levels in patients monitored on C0. Loichot C, Bentue-Ferrer D, Bernard N, Bonardet A, Boulieu R, Kergueris MF, Paintaud G, Peytavin G, Simon N, Marquet P, Therapeutic Drug Monitoring Group of the French Pharmacological Society. Fundam Clin Pharmacol; 2006 Feb; 20(1):91-6. PubMed ID: 16448399 [Abstract] [Full Text] [Related]
7. The area under the concentration-time curve versus trough and peak blood level monitoring in renal transplant recipients on cyclosporine. Halim MA, Nampoory MR, Johny KV, Donia F, Hamid MH, Said T, Nair MP, Mansour M, Al-Muzairai I, Samhan M, Al-Mousawi M. Transplant Proc; 2005 Sep; 37(7):3019-21. PubMed ID: 16213291 [Abstract] [Full Text] [Related]
8. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens. Dösch AO, Ehlermann P, Koch A, Remppis A, Katus HA, Dengler TJ. Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172 [Abstract] [Full Text] [Related]
9. The measurement of whole blood pre-treatment cyclosporine A: metabolite ratios predicts the onset of renal dysfunction in recipients of allogeneic stem cell transplantation. Stephens E, Bolderson I, Clark B, Kinsey S, Gooi HC, Cook G. Ann Clin Biochem; 2006 Sep; 43(Pt 5):382-8. PubMed ID: 17022881 [Abstract] [Full Text] [Related]
10. [Problems associated with the use and monitoring of cyclosporin. Experience at a Clinical Pharmacology Service]. Loffreda A, Contaldi C, Santis DD, Marabese I, Chiaiese C, Formato P, Motola G, Russo F, D'Alessio O, Lampa E, Rossi F. Minerva Med; 1997 Dec; 88(12):543-9. PubMed ID: 9540786 [Abstract] [Full Text] [Related]
11. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients. Shenoy S, Hardinger KL, Crippin J, Korenblat K, Lisker-Melman M, Lowell JA, Chapman W. Liver Transpl; 2008 Feb; 14(2):173-80. PubMed ID: 18236391 [Abstract] [Full Text] [Related]
12. [A new strategy for monitoring levels of cyclosporin A in the blood of patients after kidney transplantation]. Halacová M, Jedlicková B, Průsa R. Ceska Slov Farm; 2003 Nov; 52(6):267-71. PubMed ID: 14661365 [Abstract] [Full Text] [Related]
13. Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose. Sukhavasharin N, Praditpornsilpa K, Avihingsanon Y, Kuoatawintu P, O-Charoen R, Kansanabuch T, Tungsanga K, Eiam-Ong S. J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S15-20. PubMed ID: 17044449 [Abstract] [Full Text] [Related]
14. Immunosuppressive drug monitoring of sirolimus and cyclosporine in pediatric patients. Oellerich M, Armstrong VW, Streit F, Weber L, Tönshoff B. Clin Biochem; 2004 Jun; 37(6):424-8. PubMed ID: 15183289 [Abstract] [Full Text] [Related]
15. Comparison of generic cyclosporine microemulsion versus neoral in de novo renal transplant recipients managed by 2-hour postdose monitoring. Sharma A, Shekhar C, Heer M, Minz M. Transplant Proc; 2006 Sep; 38(7):2051-3. PubMed ID: 16979996 [Abstract] [Full Text] [Related]
16. [Therapeutic monitoring by blood concentrations with the focus on cyclosporin A]. Jensen SA, Dalhoff KP. Ugeskr Laeger; 2001 Apr 02; 163(14):2009-12. PubMed ID: 11307363 [Abstract] [Full Text] [Related]
17. Switching monitoring of emulsified cyclosporine from trough level to 2-hour level in stable liver transplant patients. Langers P, Cremers SC, den Hartigh J, Veenendaal RA, ten Hove WR, Ringers J, Lamers CB, van Hoek B. Liver Transpl; 2004 Feb 02; 10(2):183-9. PubMed ID: 14762854 [Abstract] [Full Text] [Related]
18. Advantages of C2 monitoring to avoid acute rejection in pediatric heart transplant recipients. Schubert S, Abdul-Khaliq H, Lehmkuhl HB, Hübler M, Abd El Rahman MY, Miera O, Ewert P, Weng Y, Wei H, Krüdewagen B, Hetzer R, Berger F. J Heart Lung Transplant; 2006 Jun 02; 25(6):619-25. PubMed ID: 16730566 [Abstract] [Full Text] [Related]